Serial founder
Manchester University spin-out C4X Discovery Holdings plc has a new CEO. UK biotech notable Clive Dix has taken over the helm of the UK drug discovery company. Dix joined C4XD as Non-Executive Chairman in October 2014 and became Executive Chairman in November 2015.
Before that, he was the co-founder and CEIO of Convergence Pharmaceuticals, which was acquired by Biogen last year. Previously, Dix founded PowderMed, a vaccines development company. He currently serves as Chairman of Touchlight Genetics and Centauri Therapeutics, and was Chairman of the UK BioIndustry Association from 2008-2010.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium